Opus Genetics, Inc.
Biotechnology
Healthcare
IRD
63.38 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.74
52 week high
1.71
high
1.74
52 week low
0.00
previous Close
1.71
P/E ratio
market cap
35.67 M
div yield
0
net incoming
-7.42 M
9.45 %
net profit margin
-257.46 %
-69.00 %
operating incoming
-8.91 M
10.30 %
net change in cash
-9.36 M
-181.62 %
cash on hand
32.43 M
-22.40 %
top